Evidence map›Paper›PMID 22215682›Full record

ArticleThe Journal of biological chemistry2012

Ringo/cyclin-dependent kinase and mitogen-activated protein kinase signaling pathways regulate the activity of the cell fate determinant Musashi to promote cell cycle re-entry in Xenopus oocytes.

Karthik Arumugam, Melanie C MacNicol, Yiying Wang, Chad E Cragle, Alan J Tackett, Linda L Hardy, Angus M MacNicol

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Translational Control of Germ Cell Decisions.Results and problems in cell differentiation · 2017
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Karthik ArumugamDepartment of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, Arkansas 722205.
Melanie C MacNicolDepartment of Neurobiology and Developmental Sciences, University of Arkansas for Medical Sciences, Little Rock, Arkansas 722205; Center for Translational Neuroscience, University of Arkansas for Medical Sciences, Little Rock, Arkansas 722205.
Yiying WangDepartment of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, Arkansas 722205.
Chad E CragleInterdisciplinary BioSciences Graduate Program, University of Arkansas for Medical Sciences, Little Rock, Arkansas 722205.
Alan J TackettDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 722205.
Linda L HardyDepartment of Neurobiology and Developmental Sciences, University of Arkansas for Medical Sciences, Little Rock, Arkansas 722205.
Angus M MacNicolDepartment of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, Arkansas 722205; Department of Neurobiology and Developmental Sciences, University of Arkansas for Medical Sciences, Little Rock, Arkansas 722205; Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas 722205. Electronic address: Angus@UAMS.edu.
University of Arkansas for Medical Sciences · USWinthrop Rockefeller Foundation · US

Funding

VIRULENCE MECHANISMS IN ESCHERICHIA COLIP20RR016460 · NCRR · UNIV OF ARKANSAS FOR MED SCIS · PI HENSLEY, LORI · 2001 to 2011
$33.1M
Structure based drug discoveryP20RR015569 · NCRR · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI MILLETT, FRANCIS S · 2000 to 2009
$21.4M
PHYSIOLOGICAL DISTURBANCES ASSOCIATED WITH NEONATAL INTRAVENTRICULAR HEMORRHAGEP20RR020146 · NCRR · UNIV OF ARKANSAS FOR MED SCIS · PI GARCIA-RILL, EDGAR E. · 2004 to 2011
$17.2M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR029884 · NCRR · UNIV OF ARKANSAS FOR MED SCIS · PI LOWERY, CURTIS L · 2009 to 2011
$11.4M
Center for Protein Structure and FunctionP30GM103450 · NIGMS · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI MILLETT, FRANCIS S · 2012 to 2014
$3.2M
Maternal gene regulation in early veterbrate developmentR01HD035688 · NICHD · UNIV OF ARKANSAS FOR MED SCIS · PI MACNICOL, ANGUS M · 1999 to 2011
$2.5M
NCRR NIH HHS P20 RR015569NCRR NIH HHS P20RR015569NCRR NIH HHS P20 RR016460NCRR NIH HHS P20 RR020146NCRR NIH HHS P20RR16460NCRR NIH HHS RR020146NCRR NIH HHS UL1 RR029884NICHD NIH HHS R01 HD035688NICHD NIH HHS R01 HD35688NIGMS NIH HHS P30 GM103450
6 · The paper itself

Abstract

Cell cycle re-entry during vertebrate oocyte maturation is mediated through translational activation of select target mRNAs, culminating in the activation of mitogen-activated protein kinase and cyclin B/cyclin-dependent kinase (CDK) signaling. The temporal order of targeted mRNA translation is crucial for cell cycle progression and is determined by the timing of activation of distinct mRNA-binding proteins. We have previously shown in oocytes from Xenopus laevis that the mRNA-binding protein Musashi targets translational activation of early class mRNAs including the mRNA encoding the Mos proto-oncogene. However, the molecular mechanism by which Musashi function is activated is unknown. We report here that activation of Musashi1 is mediated by Ringo/CDK signaling, revealing a novel role for early Ringo/CDK function. Interestingly, Musashi1 activation is subsequently sustained through mitogen-activated protein kinase signaling, the downstream effector of Mos mRNA translation, thus establishing a positive feedback loop to amplify Musashi function. The identified regulatory sites are present in mammalian Musashi proteins, and our data suggest that phosphorylation may represent an evolutionarily conserved mechanism to control Musashi-dependent target mRNA translation.

Indexed as

AnimalsCell CycleCell Cycle ProteinsCells, CulturedEvolution, MolecularMammalsMAP Kinase Signaling SystemNerve Tissue ProteinsOocytesProtein BiosynthesisProto-Oncogene Proteins c-mosRibonucleoproteinsRNA-Binding ProteinsRNA, MessengerXenopus laevisXenopus ProteinsCell Cycle Proteinsls27 protein, XenopusMos protein, XenopusMsi1 protein, XenopusNerve Tissue ProteinsProto-Oncogene Proteins c-mosRibonucleoproteinsRNA-Binding ProteinsRNA, MessengerXenopus Proteins

Identifiers

PMID22215682
PMCPMC3323046
OpenAlexW2004046421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.